Gastroesophageal reflux disease in obese patients

The role of obesity in management

Michael L. Kendrick, S. G. Houghton

Research output: Contribution to journalShort survey

25 Citations (Scopus)

Abstract

Gastroesophageal reflux disease (GERD) is common in obese patients. The implications of obesity in the etiology, management and outcomes in treatment for GERD have become increasingly important due to an epidemic of obesity. The increasing prevalence of patients with both obesity and GERD merits evaluation of the appropriate surgical intervention for GERD and its symptoms. With the additional advantages of weight loss and resolution of weight-related morbidity (including GERD) bariatric procedures should be the procedure of choice in patients with medically complicated obesity. Patients in lower obesity classes with body mass indices (BMI) of 30-35kg/m2 without other substantive weight-related comorbidity should prompt consideration of both fundoplication and bariatic procedures, tailoring the best approach based on the specific patient and future implications. Patients classified as overweight but not obese (BMI < 30) are likely best treated with fundoplication; however, no randomized trials comparing fundoplication with the current antireflux bariatic procedures exist.

Original languageEnglish (US)
Pages (from-to)57-63
Number of pages7
JournalDiseases of the Esophagus
Volume19
Issue number2
DOIs
StatePublished - Apr 2006

Fingerprint

Gastroesophageal Reflux
Obesity
Fundoplication
Body Mass Index
Bariatrics
Weights and Measures
Comorbidity
Weight Loss
Morbidity

Keywords

  • Bariatric procedures
  • Fundoplication
  • Gastric bypass
  • Gastroesophageal reflux
  • GERD
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Gastroesophageal reflux disease in obese patients : The role of obesity in management. / Kendrick, Michael L.; Houghton, S. G.

In: Diseases of the Esophagus, Vol. 19, No. 2, 04.2006, p. 57-63.

Research output: Contribution to journalShort survey

Kendrick, Michael L. ; Houghton, S. G. / Gastroesophageal reflux disease in obese patients : The role of obesity in management. In: Diseases of the Esophagus. 2006 ; Vol. 19, No. 2. pp. 57-63.
@article{b6c93763a82143aaafdfeca9ae7ce206,
title = "Gastroesophageal reflux disease in obese patients: The role of obesity in management",
abstract = "Gastroesophageal reflux disease (GERD) is common in obese patients. The implications of obesity in the etiology, management and outcomes in treatment for GERD have become increasingly important due to an epidemic of obesity. The increasing prevalence of patients with both obesity and GERD merits evaluation of the appropriate surgical intervention for GERD and its symptoms. With the additional advantages of weight loss and resolution of weight-related morbidity (including GERD) bariatric procedures should be the procedure of choice in patients with medically complicated obesity. Patients in lower obesity classes with body mass indices (BMI) of 30-35kg/m2 without other substantive weight-related comorbidity should prompt consideration of both fundoplication and bariatic procedures, tailoring the best approach based on the specific patient and future implications. Patients classified as overweight but not obese (BMI < 30) are likely best treated with fundoplication; however, no randomized trials comparing fundoplication with the current antireflux bariatic procedures exist.",
keywords = "Bariatric procedures, Fundoplication, Gastric bypass, Gastroesophageal reflux, GERD, Obesity",
author = "Kendrick, {Michael L.} and Houghton, {S. G.}",
year = "2006",
month = "4",
doi = "10.1111/j.1442-2050.2006.00540.x",
language = "English (US)",
volume = "19",
pages = "57--63",
journal = "Diseases of the Esophagus",
issn = "1120-8694",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Gastroesophageal reflux disease in obese patients

T2 - The role of obesity in management

AU - Kendrick, Michael L.

AU - Houghton, S. G.

PY - 2006/4

Y1 - 2006/4

N2 - Gastroesophageal reflux disease (GERD) is common in obese patients. The implications of obesity in the etiology, management and outcomes in treatment for GERD have become increasingly important due to an epidemic of obesity. The increasing prevalence of patients with both obesity and GERD merits evaluation of the appropriate surgical intervention for GERD and its symptoms. With the additional advantages of weight loss and resolution of weight-related morbidity (including GERD) bariatric procedures should be the procedure of choice in patients with medically complicated obesity. Patients in lower obesity classes with body mass indices (BMI) of 30-35kg/m2 without other substantive weight-related comorbidity should prompt consideration of both fundoplication and bariatic procedures, tailoring the best approach based on the specific patient and future implications. Patients classified as overweight but not obese (BMI < 30) are likely best treated with fundoplication; however, no randomized trials comparing fundoplication with the current antireflux bariatic procedures exist.

AB - Gastroesophageal reflux disease (GERD) is common in obese patients. The implications of obesity in the etiology, management and outcomes in treatment for GERD have become increasingly important due to an epidemic of obesity. The increasing prevalence of patients with both obesity and GERD merits evaluation of the appropriate surgical intervention for GERD and its symptoms. With the additional advantages of weight loss and resolution of weight-related morbidity (including GERD) bariatric procedures should be the procedure of choice in patients with medically complicated obesity. Patients in lower obesity classes with body mass indices (BMI) of 30-35kg/m2 without other substantive weight-related comorbidity should prompt consideration of both fundoplication and bariatic procedures, tailoring the best approach based on the specific patient and future implications. Patients classified as overweight but not obese (BMI < 30) are likely best treated with fundoplication; however, no randomized trials comparing fundoplication with the current antireflux bariatic procedures exist.

KW - Bariatric procedures

KW - Fundoplication

KW - Gastric bypass

KW - Gastroesophageal reflux

KW - GERD

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=33645144588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645144588&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2050.2006.00540.x

DO - 10.1111/j.1442-2050.2006.00540.x

M3 - Short survey

VL - 19

SP - 57

EP - 63

JO - Diseases of the Esophagus

JF - Diseases of the Esophagus

SN - 1120-8694

IS - 2

ER -